Cite

HARVARD Citation

    Mullens, W. et al. (2022). Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics. European journal of heart failure. pp. 1601-1610. [Online]. 
  
Back to record